Publicaciones (36) Publicaciones de Beatriz Moreno Bruna

2024

  1. CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer

    Molecular Therapy Nucleic Acids, Vol. 35, Núm. 2

2023

  1. Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Engineering U1-Based Tetracycline-Inducible Riboswitches to Control Gene Expression in Mammals

    ACS Nano, Vol. 17, Núm. 23, pp. 23331-23346

  3. Modulating T Cell Responses by Targeting CD3

    Cancers, Vol. 15, Núm. 4

2022

  1. A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 413-425

  2. IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction

    Molecular Cancer, Vol. 21, Núm. 1

  3. Therapeutic Strategies to Enhance Tumor Antigenicity: Making the Tumor Detectable by the Immune System

    Biomedicines, Vol. 10, Núm. 8

  4. U1A is a positive regulator of the expression of heterologous and cellular genes involved in cell proliferation and migration

    Molecular Therapy - Nucleic Acids, Vol. 28, pp. 831-846

2020

  1. Aptamers Against Live Targets: Is In Vivo SELEX Finally Coming to the Edge?

    Molecular Therapy - Nucleic Acids, Vol. 21, pp. 192-204

2019

  1. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation

    Neurotherapeutics, Vol. 16, Núm. 3, pp. 808-827

  2. Correction to: Methylthioadenosine promotes remyelination by inducing oligodendrocyte differentiation (Multiple Sclerosis and Demyelinating Disorders (2017) 2 (1) DOI: 10.1186/s40893-017-0020-8)

    Multiple Sclerosis and Demyelinating Disorders

  3. ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity

    Molecular Therapy, Vol. 27, Núm. 11, pp. 1878-1891

2018

  1. Mechanisms Involved in the Remyelinating Effect of Sildenafil

    Journal of Neuroimmune Pharmacology, Vol. 13, Núm. 1, pp. 6-23

2017

  1. Erratum: The disruption of mitochondrial axonal transport is an early event in neuroinflammation. [J Neuroinflammation., 12, 1, (2015)(152)] DOI: 10.1186/s12974-015-0375-8

    Journal of Neuroinflammation

2016

  1. First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases

    Science Translational Medicine, Vol. 8, Núm. 370

2015

  1. The disruption of mitochondrial axonal transport is an early event in neuroinflammation

    Journal of Neuroinflammation, Vol. 12, Núm. 1

2014

  1. Differential neuroprotective effects of 5′-deoxy-5′- methylthioadenosine

    PLoS ONE, Vol. 9, Núm. 3

  2. Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis

    Journal of Biophotonics, Vol. 7, Núm. 9, pp. 724-734

  3. Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis

    PLoS ONE, Vol. 9, Núm. 12

2013

  1. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity

    BMC Systems Biology, Vol. 7